Product References
Disruption of desmosome function leads to increased centrosome clustering in 14-3-3γ-knockout cells with supernumerary centrosomes.
FEBS letters
Tilwani S,Gandhi K,Narayan S,Ainavarapu SRK,Dalal SN
Published figure using PKP3 monoclonal antibody (Product # 35-7600) in Immunocytochemistry
Mon Nov 01 00:00:00 UTC 2021
Disruption of desmosome function leads to increased centrosome clustering in 14-3-3γ-knockout cells with supernumerary centrosomes.
FEBS letters
Tilwani S,Gandhi K,Narayan S,Ainavarapu SRK,Dalal SN
Published figure using PKP3 monoclonal antibody (Product # 35-7600) in Immunocytochemistry
Mon Nov 01 00:00:00 UTC 2021
Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
PloS one
Bowler-Barnett E,Martinez-Garcia FD,Sherwood M,Aleidan A,John S,Weston S,Wang Y,Divecha N,Skipp P,Ewing RM
35-7600 was used in Western Blot to identify several of the diverse pathways and processes associated with GSK3β function.
Wed Dec 29 00:00:00 UTC 2021
Proteomic characterization of GSK3β knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells.
PloS one
Bowler-Barnett E,Martinez-Garcia FD,Sherwood M,Aleidan A,John S,Weston S,Wang Y,Divecha N,Skipp P,Ewing RM
35-7600 was used in Western Blot to identify several of the diverse pathways and processes associated with GSK3β function.
Wed Dec 29 00:00:00 UTC 2021
Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome.
Cell reports
Ehmsen S,Pedersen MH,Wang G,Terp MG,Arslanagic A,Hood BL,Conrads TP,Leth-Larsen R,Ditzel HJ
35-7600 was used in Immunohistochemistry to identify the cholesterol biosynthesis pathway as central for CSC propagation and a potential therapeutic target, as well as providing a mechanistic explanation for the therapeutic benefit of statins in breast cancer.
Tue Jun 25 00:00:00 UTC 2019
MMP7 is required to mediate cell invasion and tumor formation upon Plakophilin3 loss.
PloS one
Basu S,Thorat R,Dalal SN
35-7600 was used in western blot to investigate the role of MMP7 in cell invasion and tumor formation
Wed Jan 13 00:00:00 UTC 2016
Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis.
PloS one
Khapare N,Kundu ST,Sehgal L,Sawant M,Priya R,Gosavi P,Gupta N,Alam H,Karkhanis M,Naik N,Vaidya MM,Dalal SN
35-7600 was used in western blot to investigate the effects of K8 filament stabilization
Thu Nov 08 00:00:00 UTC 2012
Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasis.
PloS one
Khapare N,Kundu ST,Sehgal L,Sawant M,Priya R,Gosavi P,Gupta N,Alam H,Karkhanis M,Naik N,Vaidya MM,Dalal SN
35-7600 was used in western blot to investigate the effects of K8 filament stabilization
Thu Nov 08 00:00:00 UTC 2012
Unimpaired skin carcinogenesis in Desmoglein 3 knockout mice.
PloS one
Baron S,Hoang A,Vogel H,Attardi LD
35-7600 was used in immunocytochemistry to explore the role of desmosomal cadherins in carcinogenesis.
Thu May 30 00:00:00 UTC 2013
E-cadherin and plakoglobin recruit plakophilin3 to the cell border to initiate desmosome assembly.
Cellular and molecular life sciences : CMLS
Gosavi P,Kundu ST,Khapare N,Sehgal L,Karkhanis MS,Dalal SN
35-7600 was used in immunocytochemistry and western blot to test if plakophilin3 is required for desmosome formation
Fri Apr 01 00:00:00 UTC 2011
The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.
FEBS letters
Aigner K,Descovich L,Mikula M,Sultan A,Dampier B,Bonné S,van Roy F,Mikulits W,Schreiber M,Brabletz T,Sommergruber W,Schweifer N,Wernitznig A,Beug H,Foisner R,Eger A
35-7600 was used in ChIP assay, immunocytochemistry, immunohistochemistry, and western blot to show that PKP3 is transcriptionally repressed by ZEB1 in metastatic cancer cells
Tue Apr 17 00:00:00 UTC 2007
The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.
FEBS letters
Aigner K,Descovich L,Mikula M,Sultan A,Dampier B,Bonné S,van Roy F,Mikulits W,Schreiber M,Brabletz T,Sommergruber W,Schweifer N,Wernitznig A,Beug H,Foisner R,Eger A
35-7600 was used in ChIP assay, immunocytochemistry, immunohistochemistry, and western blot to show that PKP3 is transcriptionally repressed by ZEB1 in metastatic cancer cells
Tue Apr 17 00:00:00 UTC 2007
The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.
FEBS letters
Aigner K,Descovich L,Mikula M,Sultan A,Dampier B,Bonné S,van Roy F,Mikulits W,Schreiber M,Brabletz T,Sommergruber W,Schweifer N,Wernitznig A,Beug H,Foisner R,Eger A
35-7600 was used in ChIP assay, immunocytochemistry, immunohistochemistry, and western blot to show that PKP3 is transcriptionally repressed by ZEB1 in metastatic cancer cells
Tue Apr 17 00:00:00 UTC 2007
The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.
FEBS letters
Aigner K,Descovich L,Mikula M,Sultan A,Dampier B,Bonné S,van Roy F,Mikulits W,Schreiber M,Brabletz T,Sommergruber W,Schweifer N,Wernitznig A,Beug H,Foisner R,Eger A
35-7600 was used in ChIP assay, immunocytochemistry, immunohistochemistry, and western blot to show that PKP3 is transcriptionally repressed by ZEB1 in metastatic cancer cells
Tue Apr 17 00:00:00 UTC 2007
Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
Cancer research
Furukawa C,Daigo Y,Ishikawa N,Kato T,Ito T,Tsuchiya E,Sone S,Nakamura Y
Mon Aug 15 00:00:00 UTC 2005
Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
Cancer research
Furukawa C,Daigo Y,Ishikawa N,Kato T,Ito T,Tsuchiya E,Sone S,Nakamura Y
Mon Aug 15 00:00:00 UTC 2005